High Retention Rates in Tocilizumab-Treated Patients With RA and Inadequate Response to csDMARDs, TNF hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.
Share:
Masimo (NASDAQ:MASI) announced today the findings of a study published in the
Turkish Journal of Medical Sciences in which Dr. Ayten Saracoglu and colleagues at the Marmara University Pendik Training and Research Hospital in Istanbul evaluated the ability of ORi to guide oxygenation by measuring its impact on hyperoxemia-mediated morbidity during one-lung ventilation (OLV) conducted as part of thoracic surgery.
1 They concluded that ORi-guided oxygen titration may reduce hospital stay and increase patient safety.
Masimo Root® with ORi™ (Photo: Business Wire)
ORi, available outside the U.S. since 2014, is a noninvasive and continuous parameter intended to provide additional insight into a patient s oxygen status under supplemental oxygen. Enabled by the multi-wavelength rainbow